Evidence map›Paper›PMID 24630991›Full record

ArticleCell reports2014

The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.

Megan R Edwards, Britney Johnson, Chad E Mire, Wei Xu, Reed S Shabman, Lauren N Speller, Daisy W Leung, Thomas W Geisbert, Gaya K Amarasinghe, Christopher F Basler

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Conserved Filovirus Proteins as Targets of Broad-Spectrum Antivirals.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function.Advances in experimental medicine and biology · 2024
    Review
  19. Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Megan R EdwardsDepartment Microbiology, Icahn School of Medicine, Mount Sinai, New York, NY 10029, USA.
Britney JohnsonDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Chad E MireGalveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Wei XuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Reed S ShabmanDepartment Microbiology, Icahn School of Medicine, Mount Sinai, New York, NY 10029, USA.
Lauren N SpellerDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Daisy W LeungDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Thomas W GeisbertGalveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Gaya K AmarasingheDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Christopher F BaslerDepartment Microbiology, Icahn School of Medicine, Mount Sinai, New York, NY 10029, USA. Electronic address: chris.basler@mssm.edu.
Washington University in St. Louis · USIcahn School of Medicine at Mount Sinai · USThe University of Texas Medical Branch at Galveston · US

Funding

Regulatory Compliance Core - Galveston National Laboratory BSL4 OperationsUC7AI094660 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Gene Garrard Olinger · 2011 to 2026
$208.8M
Ebola VP35 Interferon-Antagonist: Mechanism and SignifR01AI059536 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BASLER, CHRISTOPHER F · 2005 to 2015
$4.2M
Structural studies of Ebola VP35 mediated immune evasion mechanismsR01AI081914 · NIAID · WASHINGTON UNIVERSITY · PI AMARASINGHE, GAYA K. · 2009 to 2013
$2.0M
NIAID NIH HHS AI059536NIAID NIH HHS AI081914NIAID NIH HHS R01 AI059536NIAID NIH HHS R01 AI081914NIAID NIH HHS UC7 AI094660
6 · The paper itself

Abstract

Kelch-like ECH-associated protein 1 (Keap1) is a ubiquitin E3 ligase specificity factor that targets transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) for ubiquitination and degradation. Disrupting Keap1-Nrf2 interaction stabilizes Nrf2, resulting in Nrf2 nuclear accumulation, binding to antioxidant response elements (AREs), and transcription of cytoprotective genes. Marburg virus (MARV) is a zoonotic pathogen that likely uses bats as reservoir hosts. We demonstrate that MARV protein VP24 (mVP24) binds the Kelch domain of either human or bat Keap1. This binding is of high affinity and 1:1 stoichiometry and activates Nrf2. Modeling based on the Zaire ebolavirus (EBOV) VP24 (eVP24) structure identified in mVP24 an acidic loop (K-loop) critical for Keap1 interaction. Transfer of the K-loop to eVP24, which otherwise does not bind Keap1, confers Keap1 binding and Nrf2 activation, and infection by MARV, but not EBOV, activates ARE gene expression. Therefore, MARV targets Keap1 to activate Nrf2-induced cytoprotective responses during infection.

Indexed as

AnimalsAntioxidantsCytoprotectionGene ExpressionHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsKelch-Like ECH-Associated Protein 1MarburgvirusMarburg Virus DiseaseModels, MolecularNF-E2-Related Factor 2Oxidative StressProtein BindingProtein Structure, TertiarySubstrate SpecificityAntioxidantsIntracellular Signaling Peptides and ProteinsKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2Viral ProteinsVP24 protein, Marburg virus

Identifiers

PMID24630991
PMCPMC3985291
OpenAlexW2020329769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.